Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alie H. Wurie
Observed names:
A Wurie,
Alie H Wurie,
Alie Wurie,
Alieh H Wurie,
Wurie, A.H.
Institutions:
University of Sierra Leone,
Leidos Biomedical Research Inc. (United States)
Observed institutions:
University of Sierra Leone,
Ministry of Health and Sanitation,
Leidos Biomedical Research Inc. (United States)
OpenAlex ID:
A5113514301
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
2016
·
Feng-Cai Zhu
, Alie H Wurie
, et al.
·
The Lancet
·
198
New filovirus disease classification and nomenclature
2019
·
Jens H. Kuhn
, Takuya Adachi
, et al.
·
Nature Reviews Microbiology
·
135
PDF
Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study
2015
·
Marta Lado
, Naomi F Walker
, et al.
·
The Lancet Infectious Diseases
·
114
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
2021
·
Muhammed O Afolabi
, David Ishola
, et al.
·
The Lancet Infectious Diseases
·
94
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
2021
·
David Ishola
, Daniela Manno
, et al.
·
The Lancet Infectious Diseases
·
93
Epidemiology of Ebola virus disease transmission among health care workers in Sierra Leone, May to December 2014: a retrospective descriptive study
2015
·
Olushayo Olu
, Brima Kargbo
, et al.
·
BMC Infectious Diseases
·
68
PDF
Rapid assessment of Ebola infection prevention and control needs--six districts, Sierra Leone, October 2014.
2014
·
Ishani Pathmanathan
, Katherine A O'Connor
, et al.
·
PubMed
·
63
Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone
2018
·
Jessica G. Shantha
, John G. Mattia
, et al.
·
EBioMedicine
·
59
PDF
Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study
2016
·
Edward Green
, Luke Hunt
, et al.
·
The Lancet Infectious Diseases
·
36
PDF
Ebola Holding Units at government hospitals in Sierra Leone: evidence for a flexible and effective model for safe isolation, early treatment initiation, hospital safety and health system functioning
2016
·
Oliver Johnson
, Daniel Youkee
, et al.
·
BMJ Global Health
·
32
PDF
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases
2024
·
Aurélie Wiedemann
, Edouard Lhomme
, et al.
·
Nature Communications
·
23
PDF
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults
2023
·
Andrew W Lee
, Ken Liu
, et al.
·
Clinical Infectious Diseases
·
19
PDF
A challenging response to a Lassa fever outbreak in a non endemic area of Sierra Leone in 2019 with export of cases to The Netherlands
2022
·
Charles Njuguna
, Mohamed Vandi
, et al.
·
International Journal of Infectious Diseases
·
19
PDF
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
2021
·
Moses Badio
, Edouard Lhomme
, et al.
·
Trials
·
18
PDF
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
2023
·
Edward Man-Lik Choi
, Boris Lacarra
, et al.
·
The Lancet Global Health
·
17
PDF
Comprehensive Clinical and Laboratory Follow-up of a Female Patient With Ebola Virus Disease: Sierra Leone Ebola Virus Persistence Study
2019
·
William J Liu
, Foday R Sesay
, et al.
·
Open Forum Infectious Diseases
·
17
PDF
Preplanned National Measles Vaccination Campaign at the Beginning of a Measles Outbreak—Sierra Leone, 2009–2010
2011
·
David E. Sugerman
, Amadou Fall
, et al.
·
The Journal of Infectious Diseases
·
9
PDF
Atypical clinical presentation of Ebola virus disease in pregnancy: Implications for clinical and public health management
2020
·
Boris I. Pavlin
, Andrew Hall
, et al.
·
International Journal of Infectious Diseases
·
6
PDF
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial
2024
·
Simon Valayer
, Marie Alexandre
, et al.
·
Emerging Microbes & Infections
·
4
New filovirus disease classification and nomenclature
2020
·
Bah, I.E.
, Ippolito, G.
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Knowledge, attitudes and practice for Ebola virus disease in the national rapidly deployable isolation and treatment facility in Sierra Leone
2017
·
Pelagia Reidy
, Alie Wurie
, et al.
·
Journal of Infection
Show more works
View as search
Works count:
21
Citation count:
1,024
H-index:
16
I10-index:
16
Year
Topic
Type
